Literature DB >> 2500457

Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.

E A Brinton1, S Eisenberg, J L Breslow.   

Abstract

High levels of HDL-cholesterol (HDL-C) protect against coronary heart disease susceptibility, but the metabolic mechanisms underlying elevated HDL-C levels are poorly understood. We now report the turnover of isologous radioiodinated HDL apolipoproteins, apo A-I and apo A-II, in 15 female subjects on a metabolic diet with HDL-C levels ranging from 51 to 122 mg/dl. The metabolic parameters, fractional catabolic rate (FCR) and absolute synthetic rate (SR), were determined for apo A-I and apo A-II in all subjects. There was an inverse correlation between plasma HDL-C and the FCR of apo A-I and apo A-II (r = -0.75, P less than 0.001, and r = -0.54, P = 0.036, respectively), but no correlation with the SR of either apo A-I or apo A-II (r = 0.09, and r = -0.16, respectively, both P = NS). Apo A-I levels correlated inversely with apo A-I FCR (r = -0.64, P = 0.01) but not with apo A-I SR (r = 0.30, P = NS). In contrast, plasma levels of apo A-II did not correlate with apo A-II FCR (r = -0.38, P = 0.16), but did correlate with apo A-II SR (r = 0.65, P = 0.009). Further analysis showed that apo A-I and apo A-II FCR were inversely correlated with the HDL-C/apo A-I + A-II ratio (r = -0.69 and -0.61, P = 0.005 and 0.015, respectively). These data suggest that: (a) low HDL apolipoprotein FCR is the predominant metabolic mechanism of elevated HDL-C levels; (b) apo A-I FCR is the primary factor in controlling plasma apo A-I levels, but apo A-II SR is the primary factor controlling plasma apo A-II levels; (c) low HDL apolipoprotein FCR is associated with a lipid-rich HDL fraction. These findings elucidate aspects of HDL metabolism which contribute to high HDL-C levels and which may constitute mechanisms for protection against coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500457      PMCID: PMC303978          DOI: 10.1172/JCI114149

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Low serum apolipoprotein A-I in acute myocardial infarction survivors with normal HDL cholesterol.

Authors:  J Franzén; G Fex
Journal:  Atherosclerosis       Date:  1986-01       Impact factor: 5.162

2.  The influence of lipid on the conformation of human plasma high density apolipoproteins.

Authors:  S E Lux; R Hirz; R I Shrager; A M Gotto
Journal:  J Biol Chem       Date:  1972-04-25       Impact factor: 5.157

3.  In vivo metabolism of human apoprotein A-I-phospholipid complexes. Comparison with human high density lipoprotein-apoprotein A-I metabolism.

Authors:  C L Malmendier; C Delcroix; J P Ameryckx
Journal:  Clin Chim Acta       Date:  1983-07-15       Impact factor: 3.786

4.  Hydrolysis of human plasma high density lipoprotein 2- phospholipids and triglycerides by hepatic lipase.

Authors:  K Shirai; R L Barnhart; R L Jackson
Journal:  Biochem Biophys Res Commun       Date:  1981-05-29       Impact factor: 3.575

5.  Quantitation of apolipoprotein A-I of human plasma high density lipoprotein.

Authors:  J J Albers; P W Wahl; V G Cabana; W R Hazzard; J J Hoover
Journal:  Metabolism       Date:  1976-06       Impact factor: 8.694

6.  Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.

Authors:  W R Hazzard; S M Haffner; R S Kushwaha; D Applebaum-Bowden; D M Foster
Journal:  Metabolism       Date:  1984-09       Impact factor: 8.694

7.  In vitro catabolism of human plasma very low density lipoproteins. Effects of VLDL concentration on the interconversion of high density lipoprotein subfractions.

Authors:  M R Taskinen; M L Kashyap; L S Srivastava; M Ashraf; J D Johnson; G Perisutti; D Brady; C J Glueck; R L Jackson
Journal:  Atherosclerosis       Date:  1982-02       Impact factor: 5.162

8.  Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.

Authors:  K Saku; P S Gartside; B A Hynd; S G Mendoza; M L Kashyap
Journal:  Metabolism       Date:  1985-08       Impact factor: 8.694

9.  Lipoprotein-lipase action determining plasma high density lipoprotein cholesterol level in adult normolipaemics.

Authors:  M Kekki
Journal:  Atherosclerosis       Date:  1980-09       Impact factor: 5.162

10.  Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals.

Authors:  N Fidge; P Nestel; T Ishikawa; M Reardon; T Billington
Journal:  Metabolism       Date:  1980-07       Impact factor: 8.694

View more
  24 in total

1.  A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  Rapid, sensitive analysis of protein mixtures by mass spectrometry.

Authors:  R C Beavis; B T Chait
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster.

Authors:  L A Woollett; D K Spady
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones.

Authors:  Melissa N Martinez; Christopher H Emfinger; Matthew Overton; Salisha Hill; Tara S Ramaswamy; David A Cappel; Ke Wu; Sergio Fazio; W Hayes McDonald; David L Hachey; David L Tabb; John M Stafford
Journal:  J Lipid Res       Date:  2012-01-03       Impact factor: 5.922

Review 5.  Speciated High-Density Lipoprotein Biogenesis and Functionality.

Authors:  C Rosales; W S Davidson; B K Gillard; A M Gotto; H J Pownall
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

Review 6.  Influence of dietary carbohydrate and fat on LDL and HDL particle distributions.

Authors:  Patty W Siri; Ronald M Krauss
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

7.  Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway.

Authors:  Y Takahashi; J D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

8.  Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.

Authors:  I J Goldberg; W S Blaner; T M Vanni; M Moukides; R Ramakrishnan
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

9.  Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; D J Rader; T Sakamoto; M Nishiwaki; N Wakimoto; J R Schaefer; T Ishikawa; T Fairwell; L A Zech; H Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

10.  Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.

Authors:  N S Shachter; T Hayek; T Leff; J D Smith; D W Rosenberg; A Walsh; R Ramakrishnan; I J Goldberg; H N Ginsberg; J L Breslow
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.